| __timestamp | HUTCHMED (China) Limited | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 33472000 | 855506000 |
| Thursday, January 1, 2015 | 47368000 | 996170000 |
| Friday, January 1, 2016 | 66871000 | 1047690000 |
| Sunday, January 1, 2017 | 50675000 | 1324625000 |
| Monday, January 1, 2018 | 78821000 | 1416476000 |
| Tuesday, January 1, 2019 | 91944000 | 1754540000 |
| Wednesday, January 1, 2020 | 111234000 | 1829537000 |
| Friday, January 1, 2021 | 207447000 | 3051100000 |
| Saturday, January 1, 2022 | 267587000 | 2540300000 |
| Sunday, January 1, 2023 | 303055000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Infusing magic into the data realm
In the dynamic world of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Vertex Pharmaceuticals Incorporated and HUTCHMED (China) Limited have demonstrated contrasting yet fascinating trajectories in their R&D investments. From 2014 to 2023, Vertex Pharmaceuticals has consistently outpaced HUTCHMED, with R&D expenses growing by approximately 270%, peaking at over $3.16 billion in 2023. This reflects Vertex's aggressive pursuit of groundbreaking therapies, particularly in cystic fibrosis.
Conversely, HUTCHMED's R&D spending, while more modest, has seen a nearly tenfold increase, reaching around $303 million in 2023. This growth underscores HUTCHMED's commitment to expanding its oncology pipeline. The data highlights the strategic differences between these two companies: Vertex's focus on scaling existing successes versus HUTCHMED's steady expansion into new therapeutic areas.
AbbVie Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Analyzing R&D Budgets: Amgen Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Vertex Pharmaceuticals Incorporated vs Veracyte, Inc.: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Grifols, S.A. vs HUTCHMED (China) Limited
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Expenses Breakdown: Vericel Corporation vs HUTCHMED (China) Limited
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Geron Corporation